| Beryl Drugs Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524606 |
NSE Symbol : - |
P/E(TTM) : 20.34 |
|
ISIN Demat : INE415H01017 |
Div & Yield% : 0.00 |
EPS(TTM) : 1.23 |
|
Book Value(₹) : 19.45 |
Market Cap(₹Cr) : 12.69 |
Face Value(₹) : 10.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 7.30 | 5.13 | 3.78 | 5.12 | 4.79 | 3.97 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 7.30 | 5.13 | 3.78 | 5.12 | 4.79 | 3.97 |
| Other Operating Income | 0.27 | 0.34 | 0.07 | 0.04 | 0.04 | 1.25 |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income | 7.57 | 5.47 | 3.85 | 5.16 | 4.84 | 5.22 |
| Total Expenditure | 6.92 | 4.13 | 4.05 | 4.42 | 4.28 | 4.72 |
| PBIDT | 0.65 | 1.34 | -0.20 | 0.73 | 0.55 | 0.50 |
| Interest | 0.06 | 0.07 | 0.09 | 0.08 | 0.10 | 0.08 |
| PBDT | 0.59 | 1.27 | -0.29 | 0.65 | 0.45 | 0.42 |
| Depreciation | 0.32 | 0.40 | 0.32 | 0.39 | 0.38 | 0.32 |
| Tax | 0.01 | 0.03 | -0.18 | 0.11 | 0.15 | -0.15 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.04 | 0.27 | -0.26 | 0.14 | -0.10 | 0.10 |
| Reported Profit After Tax | 0.22 | 0.56 | -0.17 | 0.01 | 0.02 | 0.15 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 0.22 | 0.56 | -0.17 | 0.01 | 0.02 | 0.15 |
| EPS (Unit Curr.) | 0.44 | 1.11 | -0.33 | 0.02 | 0.04 | 0.30 |
| EPS (Adj) (Unit Curr.) | 0.44 | 1.11 | -0.33 | 0.02 | 0.04 | 0.30 |
| Calculated EPS (Unit Curr.) | 0.44 | 1.11 | -0.33 | 0.02 | 0.04 | 0.30 |
| Calculated EPS (Adj) (Unit Curr.) | 0.44 | 1.11 | -0.33 | 0.02 | 0.04 | 0.30 |
| Calculated EPS (Ann.) (Unit Curr.) | 1.74 | 4.44 | -1.32 | 0.07 | 0.17 | 1.20 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 1.74 | 4.44 | -1.32 | 0.07 | 0.17 | 1.20 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 5.07 | 5.07 | 5.07 | 5.07 | 5.07 | 5.07 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 8.90 | 26.12 | -5.29 | 14.26 | 11.48 | 12.59 |
| PBDTM(%) | 8.08 | 24.76 | -7.67 | 12.70 | 9.39 | 10.58 |
| PATM(%) | 3.01 | 10.92 | -4.50 | 0.20 | 0.42 | 3.78 |
